16-Week Data From SALWEEN Fill the Gap for Patients With PCV - Poll - MDSpire

16-Week Data From SALWEEN Fill the Gap for Patients With PCV

Discover insights from Professor Gemmy Cheung as she discusses the promising first-time data from the SALWEEN study on the use of faricimab in patients with polypoidal choroidal vasculopathy (PCV).

  • By

  • Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI

  • Michael A. Singer, MD

  • March 1, 2025

  • 9 min

Share

Original Source(s)

16-Week Data From SALWEEN Fill the Gap for Patients With PCV

  • by Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI, Michael A. Singer, MD

  • March 1, 2025

Related Content

Evaluation of Laser Doppler Holography for Assessing Choroidal Blood Flow: A Comprehensive Review of Technical Features, Validation Research, and Clinical Uses

Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy

New Product Applications: Glasses Offer Vision Enhancement With a Virtual Assistant

Two doctors have developed a groundbreaking wearable vision aid using AI technology to help individuals with low vision navigate daily activities, offering features such as a multimedia AI-powered assistant and lightweight, intuitive design.